Plus Therapeutics Inc announces positive new interim data from its ongoing ReSPECT™ Phase 1 clinical trial

Press/Media: Press / Media

PeriodNov 23 2020

Media coverage

1

Media coverage

  • TitlePlus Therapeutics Inc announces positive new interim data from its ongoing ReSPECT™ Phase 1 clinical trial
    Media name/outletImpact Financial News
    CountryUnited Kingdom
    Date11/23/20
    PersonsAndrew Brenner